ALFA Filings
Every announcement, straight from the exchange
Every Colinz Laboratories other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Colinz Laboratories Ltd submitted a non-applicability declaration for Related Party Transaction disclosures for the quarter ended September 30, 2026. The company claims exemption under Regulation 15(2).
Colinz Laboratories Ltd submitted its Integrated Filing (Financial) for the quarter and year ended March 31, 2026. The submission includes financial results and statements regarding deviations and related party transactions as per SEBI requirements.
Colinz Laboratories Ltd submitted a declaration to BSE confirming that Regulation 32 regarding Statements of Deviation or Variation is not applicable for Q4 FY2026. The company stated it did not undertake any public, rights, preferential issues, or QIPs during the quarter, indicating no deviation in fund utilisation.
Colinz Laboratories Ltd has filed a declaration stating that Related Party Transaction disclosures under Regulation 23(9) are not applicable for the quarter ended March 31, 2026. The company is claiming exemption under Regulation 15(2)(a) of SEBI (LODR) Regulations, 2015. This is a routine regulatory compliance update.